Device type · LZP
Aid, Surgical, Viscoelastic
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
LZP
Ophthalmic
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
213
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Aid, Surgical, Viscoelastic
- Product code
- LZP
- Device class
- Class III
- Review panel
- Ophthalmic
- Regulation
- 21 CFR 886.4275
- Specialty
- Ophthalmology
- FDA record
- Classification database entry for LZP
Latest FDA decisions
P220009 · Decided Feb 22, 2023 · 230 days after receipt
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
P200025 · Decided Mar 23, 2021 · 337 days after receipt
Device type: AID, SURGICAL, VISCOELASTIC (LZP) · Ophthalmology
Reports received
213
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
99
46% of reports
Injury reports
114
54% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 1 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 8 | 4 | 0 | 0 |
| Mar 24 | 2 | 7 | 0 | 0 |
| Apr 24 | 1 | 3 | 0 | 0 |
| May 24 | 6 | 1 | 0 | 0 |
| Jun 24 | 7 | 1 | 0 | 0 |
| Jul 24 | 4 | 5 | 0 | 0 |
| Aug 24 | 0 | 6 | 0 | 0 |
| Sep 24 | 1 | 1 | 0 | 0 |
| Oct 24 | 2 | 21 | 0 | 0 |
| Nov 24 | 0 | 6 | 0 | 0 |
| Dec 24 | 16 | 5 | 0 | 0 |
| Jan 25 | 1 | 1 | 0 | 0 |
| Feb 25 | 4 | 18 | 0 | 0 |
| Mar 25 | 0 | 2 | 0 | 0 |
| Apr 25 | 7 | 6 | 0 | 0 |
| May 25 | 1 | 4 | 0 | 0 |
| Jun 25 | 3 | 4 | 0 | 0 |
| Jul 25 | 5 | 9 | 0 | 0 |
| Aug 25 | 0 | 2 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 2 | 3 | 0 | 0 |
| Nov 25 | 5 | 2 | 0 | 0 |
| Dec 25 | 5 | 18 | 0 | 0 |
| Jan 26 | 10 | 6 | 0 | 0 |
| Feb 26 | 2 | 12 | 0 | 0 |
| Mar 26 | 7 | 0 | 0 | 0 |
| Apr 26 | 6 | 8 | 0 | 0 |
| May 26 | 0 | 16 | 0 | 0 |
| Jun 26 | 13 | 5 | 0 | 0 |
| Jul 26 | 13 | 15 | 0 | 0 |
| Aug 26 | 9 | 15 | 0 | 0 |
| Sep 26 | 9 | 3 | 0 | 0 |
| Oct 26 | 20 | 14 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- AMO Uppsala104
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Contamination94
- Adverse Event Without Identified Device or Use Problem82
- Insufficient Device Problem Information15
- Defective Component9
- Mechanical Problem9
- Device Handling Problem5
- Appropriate Device Problem Term/Code Not Available2
- Device Difficult to Setup or Prepare2
- Improper Flow or Infusion2
- Device Dislodged or Dislocated1
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions95
- Toxic Anterior Segment Syndrome (TASS)34
- Corneal Edema18
- Endophthalmitis18
- Eye Injury17
- Hypopyon13
- Inflammation13
- Visual Disturbances12
- Loss of Vision10
- Intraocular Pressure Increased9
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Johnson & Johnson Surgical Vision, Inc.
Z-3064-2026 · Started Jul 31, 2026 · Posted by FDA Aug 31, 2026
Reason given: Surgical instructions sent for viscoelastic products used during ophthalmic viscosurgical cataract procedures including in part: If resistance is encountered during insertion, withdraw cannula and reassess the insertion conditions (i.e. insertion angle, incision size, etc.) before proceeding because forcing the...
Cause as FDA categorized it: Device Design
Johnson & Johnson Surgical Vision Inc
Z-0867-2020 · Started Dec 3, 2019 · Posted by FDA Jan 27, 2020
Reason given: Ophthalmic viscosurgical device may be difficult to remove from the eye, leading to increased postoperative intraocular pressure requiring additional intervention. Also, reports of clogging of phacoemulsion equipment tubing, which may lead to delay in the procedure or ocular injury.
Cause as FDA categorized it: Labeling False and Misleading
Abbott Medical Optics Inc. (AMO)
Z-2062-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design
Abbott Medical Optics Inc. (AMO)
Z-2063-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design
Abbott Medical Optics Inc. (AMO)
Z-2064-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design
- Healon 5 Pro, Part No. 10270015Terminated
Abbott Medical Optics Inc. (AMO)
Z-2065-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design
- Healon Pro, Part No. 10270012Terminated
Abbott Medical Optics Inc. (AMO)
Z-2066-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design
- Healon V, Part No. 10290045Terminated
Abbott Medical Optics Inc. (AMO)
Z-2067-2017 · Started Apr 1, 2017
Reason given: Remote possibility that certain solutions in these lots may contain microscopic glass particles due to damage that occurred at the cylinder neck during the manufacturing process.
Cause as FDA categorized it: Process design
Showing the 8 newest of 25 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.